All
LDN for Autoimmune Conditions: What Has Actually Been Studied?

LDN for Autoimmune Conditions: What Has Actually Been Studied?

Low Dose Naltrexone is often discussed as one treatment for “autoimmune disease,” but the evidence differs dramatically by condition. Compare the actual LDN studies involving...

Read article
How to Choose an LDN Compounding Pharmacy: 10 Questions

How to Choose an LDN Compounding Pharmacy: 10 Questions

Not all compounded LDN is identical. Before choosing a pharmacy, patients should look beyond price and ask about licensure, PCAB accreditation, ingredient sourcing, third party...

Read article
Low Dose Naltrexone for Fibromyalgia, 2026 Evidence and what Research shows

Low Dose Naltrexone for Fibromyalgia, 2026 Evidence and what Research shows

LDN has become one of the most talked-about options for fibromyalgia, but the newest evidence is challenging the hype. See why early studies looked promising,...

Read article
What Is Low Dose Naltrexone? Uses, Evidence, Safety, and Compounding

What Is Low Dose Naltrexone? Uses, Evidence, Safety, and Compounding

What is Low Dose Naltrexone, and what does the evidence really show? Learn how LDN differs from standard naltrexone, why its common...

Read article
Should You Do a Parasite Cleanse? What the Growing Cyclospora Outbreak Teaches Us About Parasites, Prescription Treatments & Gut Health

Should You Do a Parasite Cleanse? What the Growing Cyclospora Outbreak Teaches Us About Parasites, Prescription Treatments & Gut Health

As the nationwide Cyclospora outbreak continues to grow, more Americans are searching for answers about parasite cleanses, digestive symptoms, and prescription treatments. But not every...

Read article
LDN, Peptides, and Personalized Functional Medicine: What the FDA Vote Really Means

LDN, Peptides, and Personalized Functional Medicine: What the FDA Vote Really Means

Six popular peptides just received favorable FDA advisory committee votes, but they were not FDA approved, and the votes did not prove efficacy. Discover how...

Read article